Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Riot Blockchain, Inc. | ex99x1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 26, 2010
AspenBio Pharma, Inc.
(Exact name of Registrant as specified in its charter)
|
Colorado
|
001-33675
|
84-155338
|
||
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
1585 South Perry Street
Castle Rock, Colorado
|
80104
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code (303) 794-2000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On October 26, 2010, AspenBio Pharma, Inc. (the “Company”) issued a press release titled — “AspenBio Advances AppyScore™ Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise.” The press release is filed as Exhibit 99.1 to this Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibits
|
99.1
|
Press release, dated October 26, 2010, issued by AspenBio Pharma, Inc. titled “AspenBio Advances AppyScore™ Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise.”
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized
|
AspenBio Pharma, Inc.
(Registrant)
|
||||
|
Date: October 26, 2010
|
By:
|
/s/ Jeffrey G. McGonegal
|
||
| Name: Jeffrey G. McGonegal | ||||
| Title: Chief Financial Officer | ||||